ArticleBMC cancer2025

The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model.

Vijayalaxmi G Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.